ARE-Luc/EF1α-mCherry Reporter Cell Line - NIH3T3

The ARE-Luc/EF1α-mCherry reporter cell line (based on NIH3T3) is a stable reporter cell line derived from the mouse embryonic fibroblast line NIH3T3, designed to monitor the activity of the Antioxidant Response Element (ARE) signaling pathway. This cell line contains a luciferase reporter gene driven by an ARE-responsive promoter, allowing for the quantitative detection of pathway activation via bioluminescence. Additionally, the cells express the fluorescent protein mCherry under the control of a constitutive EF1α promoter, serving as a convenient fluorescent marker for cell identification, tracking, and the assessment of transfection efficiency or population stability. By combining a pathway-specific luciferase signal with a constitutive red fluorescent signal, this dual-reporter system is highly suitable for conducting reproducible experiments and performing routine quality control. Compared to transiently transfected cells, this stable NIH3T3-based system offers greater consistency, making it ideal for long-term screening studies.

The ARE-Luc/EF1α-mCherry reporter cell line (based on NIH3T3) can be used to investigate the activation and regulatory mechanisms of the Nrf2-ARE pathway—a pathway that plays a critical role in cellular defense against oxidative stress, electrophilic compounds, inflammation, and environmental damage. It is well-suited for evaluating the antioxidant and cytoprotective effects of small-molecule compounds, natural products, drug candidates, and other test substances. Furthermore, this cell line can be employed for dose-response studies, the exploration of pathway mechanisms, compound screening, and preliminary toxicity assessments. While luciferase activity provides a sensitive, quantitative readout of ARE activation, mCherry fluorescence facilitates cell monitoring, data normalization, and the detection of changes in cell number or morphology. Researchers can utilize this model for drug discovery, oxidative stress research, the evaluation of nutraceuticals, and the development of therapeutics targeting redox homeostasis. This cell line provides a convenient and scalable assay platform, facilitating the efficient screening and identification of compounds capable of modulating the Nrf2-dependent antioxidant response.